Systematic review of performance of non-invasive biomarkers in the evaluation of non-alcoholic fatty liver disease
Liver International. 2011;31(4):461-473 
Non-invasive biomarkers of liver fibrosis in non-alcoholic fatty liver disease
Clinical and Molecular Hepatology. 2023;29(2):398-400
P.04.16 NON INVASIVE FIBROSIS AND FATTY LIVER ASSESSMENT IN NON ALCOHOLIC FATTY LIVER DISEASE (NAFLD) IN REAL LIFE
Digestive and Liver Disease. 2019;51:e178-e179
Liver Fibrosis in Non-alcoholic Fatty Liver Disease: From Liver Biopsy to Non-invasive Biomarkers in Diagnosis and Treatment
Frontiers in Medicine. 2021;8:
Diagnosis of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis: Non-invasive tests are enough
Liver International. 2018;38:67-70
Combination of non-invasive fibrosis tests: a solution for the prediction of advanced fibrosis in non-alcoholic fatty liver disease?
Journal of Gastrointestinal and Liver Diseases. 2019;28(3):257-259
Non-Invasive Assessment of Fibrosis Progression in Non-Alcoholic Fatty Liver Disease
Journal of Hepatology. 2016;64(2):S473
AST to Platelet Ratio Index and fibrosis 4 calculator scores for non-invasive assessment of hepatic fibrosis in patients with non-alcoholic fatty liver disease
Digestive and Liver Disease. 2017;49(10):1133-1138
Serum ferritin as a non-invasive marker in the prediction of hepatic fibrosis among Egyptian patients with non-alcoholic fatty liver disease
JGH Open. 2017;1(3):112-119
Steatosis affects the sensitivity but not the specificity of non-invasive fibrosis tests in non-alcoholic fatty liver disease - implications for screening strategies
Liver International. 2018;38(2):224-226